Cerebrolysin

Formulation: Sterile injectable solution

Concentration: 215.2 mg/ml solution (commonly supplied in 1 ml, 5 ml, or 10 ml ampoules)

Composition: Low–molecular weight neuropeptides + free amino acids

Half-Life: Variable; peptides cross the blood-brain barrier rapidly

Primary Actions: Neurotrophic activity (NGF-like), neuroprotection, synaptic repair, cognitive enhancement

Demonstrated clinical efficacy in ischemic stroke recovery (improves functional outcomes and neuroplasticity).

Shown to slow cognitive decline in Alzheimer’s and vascular dementia.

Promotes neuronal survival, synaptic plasticity, and neurogenesis via neurotrophic factor–like activity.

Provides anti-apoptotic, antioxidant, and anti-inflammatory effects in the CNS.

Supplied as ready-to-use injectable ampoules (no reconstitution required).

Administered intramuscularly (IM) or intravenously (IV) depending on research protocol.

Use aseptic technique when opening ampoules to maintain sterility.

Unopened: Store at 2–25 °C (do not freeze).

Opened: Use immediately after opening ampoule; discard remainder.

Appearance: Clear to slightly yellowish solution. Discard if cloudy or particulate matter appears.

Category: Cognitive & Neuroregeneration Optimization (NuroCore)

Use Case: Investigated in clinical and experimental settings for stroke, Alzheimer’s, TBI, and neurodegeneration.

Compliance Note: Regulated as a prescription neuropeptide preparation in many countries; for NuroCore catalog, positioned under advanced cognitive support research compounds.